BIOMAT Database Logo BIOMAT Database Logo

Low dose of ACE-inhibitor enhances sodium excretion in volume expanded patients with borderline hypertension. 1996

C Borghi, and S Boschi, and F V Costa, and S Bacchelli, and D Degli Esposti, and V Immordino, and M Piccoli, and F Ambrosioni
Third Department of Internal Medicine, Department of Clinical Pharmacology and Therapeutics, University of Bologna, Italy.

The purpose of the present study was to separately investigate the effects of two different dosages of captopril on pressor, vascular and humoral response to acute extracellular volume expansion in patients with borderline hypertension (BHT). Thirty-five patients were randomly allocated in two groups undergoing acute saline infusion (0.40 ml/min/kg for 45 min and 0.15 ml/min/kg for 75 min)before and after a 7-day period of treatment with either placebo or captopril at the dose of 12.5 (LD-CAP) or 50 mg (HD-CAP) twice a day. At baseline the effects of LD-CAP were limited to an increase in PRA and to a decrease in plasma aldosterone whereas HD-CAP decreased systolic and diastolic blood pressure (SBP, DBP), forearm vascular resistance (FVR) and increased venous distensibility (VV(30)) as well. After saline loading patients treated with HD-CAP showed an increase in SBP, DBP not observed in patients allocated to LD-CAP. Urinary sodium excretion in response to NaCl loading was selectively enhanced by LD-CAP (+25%) whereas HD-CAP did not (+6.3%). The present data suggest that low-doses of ACE-inhibitors acting through a selective blockade of RAA not associated with hemodynamic changes can enhance the natriuretic response to acute volume expansion in borderline hypertensives.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D009318 Natriuresis Sodium excretion by URINATION. Natriureses
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses

Related Publications

C Borghi, and S Boschi, and F V Costa, and S Bacchelli, and D Degli Esposti, and V Immordino, and M Piccoli, and F Ambrosioni
ACE inhibition facilitates sodium and water excretion during PEEP in conscious volume-expanded dogs.
September 1992, Journal of applied physiology (Bethesda, Md. : 1985),
C Borghi, and S Boschi, and F V Costa, and S Bacchelli, and D Degli Esposti, and V Immordino, and M Piccoli, and F Ambrosioni
The sodium-potassium pump in volume expanded hypertension.
January 1978, Clinical and experimental hypertension,
C Borghi, and S Boschi, and F V Costa, and S Bacchelli, and D Degli Esposti, and V Immordino, and M Piccoli, and F Ambrosioni
Humoral sodium transport inhibitor in acute volume expansion and low renin hypertension.
November 1987, Hypertension (Dallas, Tex. : 1979),
C Borghi, and S Boschi, and F V Costa, and S Bacchelli, and D Degli Esposti, and V Immordino, and M Piccoli, and F Ambrosioni
Significant suppressive effect of low-dose temocapril, an ACE inhibitor with biliary excretion, on FGS lesions in hypertensive rats.
December 2000, Nephron,
C Borghi, and S Boschi, and F V Costa, and S Bacchelli, and D Degli Esposti, and V Immordino, and M Piccoli, and F Ambrosioni
Low sodium excretion in SIADH patients with low diuresis.
January 2004, Nephron. Physiology,
C Borghi, and S Boschi, and F V Costa, and S Bacchelli, and D Degli Esposti, and V Immordino, and M Piccoli, and F Ambrosioni
Comparison of effects of combined ACE inhibitor and low-dose thiazide diuretic with ACE inhibitor alone on insulin action in patients with hypertension and Type 2 diabetes: a double-blind crossover study.
May 2008, Diabetic medicine : a journal of the British Diabetic Association,
C Borghi, and S Boschi, and F V Costa, and S Bacchelli, and D Degli Esposti, and V Immordino, and M Piccoli, and F Ambrosioni
[Effect of low-sodium diet on urinary catecholamine excretion in patients with arterial hypertension].
July 1972, Polski tygodnik lekarski (Warsaw, Poland : 1960),
C Borghi, and S Boschi, and F V Costa, and S Bacchelli, and D Degli Esposti, and V Immordino, and M Piccoli, and F Ambrosioni
Humoral factors and the sodium-potassium pump in volume expanded hypertension.
June 1979, Life sciences,
C Borghi, and S Boschi, and F V Costa, and S Bacchelli, and D Degli Esposti, and V Immordino, and M Piccoli, and F Ambrosioni
Enhanced red cell sodium permeability in patients with borderline hypertension.
January 1986, Japanese heart journal,
C Borghi, and S Boschi, and F V Costa, and S Bacchelli, and D Degli Esposti, and V Immordino, and M Piccoli, and F Ambrosioni
Low-dose diuretic and/or dietary sodium restriction when blood pressure is resistant to ACE inhibitor.
November 1998, Blood pressure,
Copied contents to your clipboard!